mNSET™ (Non-Surgical Embryo Transfer) Device for Mice 60010 (10 Devices per box)
60010 (10 devices per box)
$275.00
This item is currently in stock!
For AI and pathogen transfer, see product 60020.
10 Devices/Box
ParaTechs’ mNSET™ (Non-Surgical Embryo Transfer) Device for Mice 60010 revolutionizes mouse uterine embryo transfer by reducing cost and eliminates the need for animal anesthesia and recovery normally required for conventional surgical procedures. Compare this methodology with the time, expense, and training required to accomplish the same task with other methods and you will discover that the NSET procedure is humane, quick, and cost effective.
The mNSET Device for Mice 60010 is manufactured in the USA, solely for ParaTechs Corporation, by an FDA Registered Medical Device Manufacturer and ISO 13485:2003 Registered Company and is EtO (Ethylene Oxide) sterilization processed. Patent Information: Non-Surgical Embryo Transfer Method and Apparatus, United States Patent 9,615,903. [PDF]
Harmonized Tariff: 3926.90.9910
10% Discount on orders of 10 or more boxes. Discount applies automatically at checkout.
mNSET 60010 Videos
Watch the mouse NSET demonstration videos:
- mNSET 60010 Full Procedure Demonstration Video
- mNSET 60010 Quick Procedure Only Video
mNSET 60010 Webinars
Watch both webinars presented by Dr. Barbara Stone, Director of Rodent Assisted Reproductive Technologies, ParaTechs Corporation
- Rodent Embryo Transfer and the 3Rs
- The Future of Mouse Embryo Transfer: Achieving the 3Rs with the NSET Device
Uses
Mouse Embryo Transfer:
- Embryo transfer after DNA microinjection
- ES cell chimeric blastocyst transfer
- Cryopreserved embryo transfer
- Embryo transfer after in vitro fertilization
- Embryo transfer for rederivation
Other:
- Small volume material transfer to the uterine horn. For larger volume transfer, please consider the mC&I device which has a 40µl capacity.
- Mouse Sperm Transfer for Artificial Insemination (AI): Fresh sperm
- Pathogen Transfer: Chlamydia trachomatis
- Material Transfer:
- Decidualization procedures
- Pharmaceuticals
Advantages
- Eliminates the pain and distress of surgery
- No anesthesia required
- Eliminates need for post-surgical monitoring of animals
- Reduces regulatory burden by eliminating need to justify survival surgery
- Eliminates surgical instruments and time-consuming pre- and post-surgical processes
- Greatly reduces time required to become proficient in embryo transfer or artificial insemination (AI)
- Reduces costs of embryo transfer
- Reduces costs of AI
- Easy procedure
- Convenient
- Sterile and ready to use
- 3Rs implementation (Reduce & Refine)